NAD+ intranasal formulations are investigated in experimental models to characterize mucosal transport and central nervous system distribution through olfactory or trigeminal pathways.
For laboratory research use only. Not for human or veterinary use.
NAD+ is the oxidized form of nicotinamide adenine dinucleotide, a coenzyme studied in cellular metabolism and redox reactions. This liquid spray-format product contains 750 mg total NAD+ in a 15 mL bottle.
Research on NAD+ includes:
| Total Content | Volume | Concentration | 0.1 mL | 0.2 mL | 0.4 mL | 1.0 mL |
|---|---|---|---|---|---|---|
| 750mg | 15mL | 50mg/mL | 5mg | 10mg | 20mg | 50mg |
Quantified to verify concentration within accepted labeled specification.
Assessed for peptide purity and absence of significant impurities by analytical methods.
Confirmed by analytical testing to match reference peptide characteristics.
Batch records and test data maintained for traceability and transparency.
Tested for potency, purity, and identity verification. COA generated for the current production batch.
Unreconstituted
Store at -20°C to 4°C (freezer or refrigerator). Stable for 24+ months.
Reconstituted
Refrigerate at 2–8°C. Use within 30 days for optimal stability.
Avoid
Repeated freeze-thaw cycles, direct sunlight, and temperatures above 25°C.
No. NAD+ is a coenzyme, not a peptide.
Based on 750 mg total content in 15 mL, the calculated concentration is 50 mg/mL.
That depends on the pump’s output volume. The amount per spray cannot be calculated from the bottle concentration alone.
